Successful partnerships between pharma and diagnostic companies are built using a strong, clearly-defined process that helps to avoid potential commercialization challenges. They require careful management and alignment, particularly now that regulatory bodies are moving towards a joint review of the diagnostic and therapy. Diaceutics can help you make a considered partnering decision by providing access to our index of diagnostic companies, ranked by technology and disease indication.